The NCRI Bladder & Renal Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of bladder and renal cancer. The Group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for bladder and renal cancer patients.
The NCRI Bladder & Renal Group consists of an executive Group, chaired by Professor Robert Jones, which provides oversight of the research landscape and proactively identifies opportunities for the Group. The NCRI Bladder & Renal Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive Group and subgroups twice a year.
The NCRI Bladder & Renal Group was formed when the NCRI Bladder Group and NCRI Renal Group merged in 2015.